Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01148
Full Text
Open PDFAbstract
Available in full text
Date
May 28, 2019
Authors
Publisher
Frontiers Media SA